Teladoc (NYSE:TDOC) shares plunged more than 20% after-hours following the company’s reported Q2 results, with EPS of ($19.22) coming in significantly lower than the consensus estimate of ($0.64). Revenue increased 18% year-over-year to $592.4 million, compared to the consensus estimate of $587.71 million.
Access fees revenue came in at $518.7 million (up 20% year-over-year) and visit fee revenue at $66.7 million (up 7% year-over-year). U.S. Revenues increased 18% year-over-year to $521.4 million and International revenues increased 13% year-over-year to $71.0 million.
The company expects Q3/22 EPS of ($0.85)-($0.60), compared to the consensus of ($0.55), and revenue of $600-620 million, compared to the consensus of $613.73 million.
For the full 2022-year, the company expects EPS of ($62.00)-($61.00), compared to the consensus of ($42.89), and revenue of $2.4-2.5 billion, compared to the consensus of $2.43 billion.
By Davit Kirakosyan